ClinicalTrials.gg
RecruitingNCT06768060Updated Mar 18, 2026

Mindfulness-based Intervention Prior to External Cephalic Version

An interventional study of Short mindfulness-based intervention in Breech Presentation in Pregnancy and External Cephalic Version, sponsored by Catharina Ziekenhuis Eindhoven. Recruiting at 1 site in Netherlands. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-18.

Sponsored by Catharina Ziekenhuis Eindhoven · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Feb 2025; still recruiting 1 year 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
148
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The study is a randomized controlled trial examining the effectiveness of a short mindfulness-based intervention on the success rate of external cephalic version in pregnant women with breech presentation. It is hypothesized that this intervention will increase the ECV success rate and decrease the pain experienced after the ECV.

02

Conditions studied

  • Breech Presentation in Pregnancy
  • External Cephalic Version

Browse trials for

Keywords

  • Breech presentation
  • Pregnancy
  • External cephalic version
  • Mindfulness intervention
03

In context

Breech Presentation

41 studies on the registry are indexed under Breech Presentation; 10 are open to participants now.

This study's planned enrollment of 148 is above the median of 119 across 31 interventional studies indexed under Breech Presentation.

Browse Breech Presentation studies →

Lead sponsor

Catharina Ziekenhuis Eindhoven is the lead sponsor of 85 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Pregnant women (18+y).
  • With a breech presenting fetus undergoing external cephalic version.
  • Dutch/English-speaking or understanding Dutch/English.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Care provider)
Enrollment
148 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Short mindfulness-based intervention (5 minutes) prior to the external cephalic version

    Behavioral: Short mindfulness-based intervention

  • No intervention
    Control group

    Care as usual

Interventions

  • BehavioralShort mindfulness-based intervention

    The intervention includes a short mindfulness-based intervention with a duration of 5 minutes. It involves a sitting mediation focused on breath adapted from the existing protocols of the Mindfulness-Based Stress Reduction (MBSR) and Mindfulness-Based Cognitive Therapy (MBCT). The intervention is audio-guided and will be delivered via headphones.

06

What researchers measure

Primary outcomes

  1. Post-intervention external cephalic version success rate

    The success rate of the external cephalic versions (successful/not successful) will be compared between the intervention and control group.

    Time frame: 1 hour after enrollment (i.e., in hospital, after intervention and external cephalic version)

Secondary outcomes

  1. Post-intervention pain perception

    The pain experienced during the external cephalic version will be assessed with a visual analogue scale (VAS). The mean/median VAS scores will be compared between the intervention and control group. The scores range between 0 and 10, with a higher score indicating more experienced pain.

    Time frame: 1 hour after enrollment (i.e., in hospital, after intervention and external cephalic version)

  2. Post-intervention comfort

    Comfort during the external cephalic version will be assessed with a visual analogue scale (VAS). The mean/median VAS scores will be compared between the intervention and control group. The scores range between 0 and 10, with a higher score indicating more comfort.

    Time frame: 1 hour after enrollment (i.e., in hospital, after intervention and external cephalic version)

Other outcomes

  1. Baseline mindfulness skills

    Baseline mindfulness skills are assessed with the 15-item Three Facet Mindfulness Questionnaire Short Form (TFMQ-SF), consisting of the facets acting with awareness, non-judging and non-reacting. The total score ranges from 0 to 60, with higher scores indicating better mindfulness skills. The validity of the measure is established and indices of internal reliability were found to be adequate.

    Time frame: At baseline (i.e., in hospital, prior to intervention and external cephalic version)

  2. Baseline depressive symptoms

    Assessed with the 10-item Edinburgh Postnatal Depression Scale (EPDS). The EPDS is the most widely used self-rating scale to assess depressive symptoms in the perinatal period. The EPDS total score ranges from 0 to 30, with higher scores indicating more depressive symptoms. The questionnaire has been validated in Dutch postpartum women.

    Time frame: At baseline (i.e., in hospital, prior to intervention and external cephalic version)

  3. Baseline fear of external cephalic version

    Assessed with a visual analogue skill (VAS), by which participants indicate how anxious they feel about the upcoming external cephalic version. The scores range from 0 to 10, with higher scores indicating more anxiety about the upcoming external cephalic version.

    Time frame: At baseline (i.e., in hospital, prior to intervention and external cephalic version)

  4. Post-intervention general questions

    Three general questions about the information that women received during the external cephalic version, and the familiarity with mindfulness/yoga.

    Time frame: 1 hour after enrollment (i.e., in hospital, after intervention and external cephalic version)

  5. Post-intervention evaluation of the intervention

    Four questions about how women perceived the intervention (intervention group only)

    Time frame: 1 hour after enrollment (i.e., in hospital, after intervention and external cephalic version)

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06768060
Lead sponsor
Catharina Ziekenhuis Eindhoven
Collaborators
Tilburg University
Responsible party
Simone Kuppens (Principal Investigator, Catharina Ziekenhuis Eindhoven) — Principal investigator
First posted
Jan 10, 2025
Start date
Feb 27, 2025
Primary completion
Jan 31, 2028 (estimated)
Completion
Jan 31, 2028 (estimated)
Last update
Mar 18, 2026

Study contacts

Simone MI Kuppens, MD, PhD
Contact
simone.kuppens@catharinaziekenhuis.nl
0031402399300
Lianne P Hulsbosch, PhD
Contact
l.p.hulsbosch@tilburguniversity.edu
0134664213

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion